A published meta-analysis for BRCA1-related tumors reported a worse outcome among the breast cancer patients carrying a mutated BRCA gene [7], while BRCA1 mutated ovarian cancer patients had a more favorable clinical outcome [9]. Here, BRCA1 is linked to ovarian carcinoma.